Product Information
DESOXIMETASONE 0.25% CREAM is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3227 per GM under NDC 68180095002. Its NADAC has been published 477 times since Aug 16, 2017.
FDA first approved this application on Jan 9, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/g
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180095002
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DESOXIMETASONEApproval Type
Generic (ANDA)
FDA Application
ANDA208164FDA Approved
1/9/2017
TE Code
AB
On Market Since
6/20/2017
Pharmacological Classes
Price Statistics
The NADAC for DESOXIMETASONE 0.25% CREAM has been published 477 times since Aug 16, 2017, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3227 per GM |
|---|---|
| All-time high | $0.8480 (Aug 16, 2017) |
| All-time low | $0.2320 (Nov 20, 2024) |
| 52-week high | $0.3248 |
| 52-week low | $0.3057 |
| Median price | $0.4550 |
| Average price | $0.4785 |
| Largest weekly change | +53.3% (May 17, 2023) |
| Weeks tracked | 477 |
| Tracking since | Aug 16, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desoximetasone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESOXIMETASONE 0.25% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for DESOXIMETASONE 0.25% CREAM, manufactured by Lupin Pharmaceuticals Inc., is $0.3227 per GM (NDC 68180095002), effective Sep 30, 2026.
How has the price of DESOXIMETASONE 0.25% CREAM changed over time?
Over the history we have for it, the NADAC for DESOXIMETASONE 0.25% CREAM has declined 61.9%. It has been tracked across 477 weekly CMS publications since Aug 16, 2017.
What are the highest and lowest recorded NADAC prices for DESOXIMETASONE 0.25% CREAM?
Since Aug 16, 2017, the NADAC for DESOXIMETASONE 0.25% CREAM has ranged from a low of $0.2320 (Nov 20, 2024) to a high of $0.8480 (Aug 16, 2017), with a median of $0.4550 per GM.
Are there cheaper alternatives to DESOXIMETASONE 0.25% CREAM?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DESOXIMETASONE 0.25% CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures DESOXIMETASONE 0.25% CREAM?
DESOXIMETASONE 0.25% CREAM (NDC 68180095002) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.